tacrolimus Articles
News briefs from Genmab/Kyowa Hakko; Alimera/Quintiles; Novo Nordisk; Astellas; Sandoz
5 December 2012
Veloxis Pharma in LCP-Tacro deal with Chiesi
7 October 2012
Substitution of brand name tacrolimus with generic proves safe for transplant recipients
14 September 2011
Mylan gets US approval for copy version of Astellas’ immunosuppressant Prograf; Teva files complaint over Copaxone patents
22 September 2010
Japanese drug major Astellas’ 3rd quarter net profit slumps 47% as Prograf hit by generic competition
3 February 2010
US court rejects Astellas’ appeal on generic immunosuppressants
14 September 2009
Japan stock market week to June 8, 2009
9 June 2009
Japan stock market week to May 18, 2009
19 May 2009
Japan stock market week to Feb 9, 2009
16 February 2009
Astellas' revenue up 2% in first half of year
8 December 2008
Japan stock market week to Nov 10, 2008
17 November 2008
Japan stock market week to Nov 3, 2008
10 November 2008
Japan stock market week to Oct 6, 2008
13 October 2008
Japan stock market week to Sept 15, 2008
22 September 2008
Astellas looking to overtake Takeda's leading share of home market with newer products
15 September 2008
Japan stock market week to August 4, 2008
11 August 2008
Astellas' modified Prograf Oked in Japan
28 July 2008
Astellas' fiscal 2007 sales increase 5.6%
2 June 2008
Japan stock market week to May 19, 2008
26 May 2008
Tokyo stocks to May 12, 2008
19 May 2008
Japan stock market week to March 24, 2008
31 March 2008
US "approvable" letter for Astellas' FK506
24 March 2008
Japan stock market week to March 10, 2008
17 March 2008
Tokyo stocks to February 11, 2008
18 February 2008
Myfortic cuts GI effects in transplant recipients
14 January 2008
Japan stock market week to Nov 12, 2007
19 November 2007
Japan stock market week to September 24, 2007
1 October 2007
Japan stock market week to Sept 17, 2007
24 September 2007
Japan stock market week to August 6, 2007
13 August 2007
Advagraf launched in UK and Germany
25 June 2007
Japan stock market week to May 21, 2007
28 May 2007
Japan stock market week to May 7, 2007
14 May 2007
Astellas' Advagraf approved in Europe
7 May 2007
Data supports CellCept transplant regimen
9 April 2007
Japan stock market week to March 5, 2007
12 March 2007
Astellas' FK506 gets positive opinion from CHMP
5 March 2007
Japan stock market week to Feb 5, 2007
12 February 2007
Japan stock market week to June 25, 2007
7 February 2007
Japan stock market week to Jan 29, 2007
5 February 2007
Astellas' fiscal 06/07 first-half net sales rise 5%
20 November 2006
Japan stock market week to October 9, 2006
16 October 2006
Japan stock market week to Aug 7, 2006
14 August 2006
Novartis' Neoral performs well in study
31 July 2006
Positive kidney transplant data for Atellas' Prograf
26 July 2006
Japan stock market week to July 3, 2006
10 July 2006
Japan stock week to June 5
12 June 2006
Astellas submits FK506 MAA to PMDA
5 June 2006
Strong six month data for Sorin's Janus stent
5 June 2006
Prograf gets FDA OK for heart transplant care
10 April 2006
Astellas sees solid fiscal 1st-qtr 2006
20 February 2006
Japan stock market week to Feb 6, 2006
13 February 2006
Ph IIb trial of Isotechnika's ISA247 opens
16 January 2006
Japan stock market 3 weeks to Jan 2, 2006
9 January 2006
Danger to patients from weak US Rx system: CU
12 December 2005
Positive results with Sorin's Janus drug-eluting stent
12 September 2005
Astellas: merger costs cause 75% profit drop
30 May 2005
Japan stock market week to May 23
30 May 2005
Corgentech's eczema drug advances to Ph I/II
16 May 2005
Japan stock market week to April 18
25 April 2005
Astellas' Prograf approved for rheumatoid arthritis
18 April 2005
Fujisawa's 9-month sales rise 2.5%
21 February 2005
EWGAD highlights Protopic as superior in atopic dermatitis
20 December 2004
Aspirations of Astellas Pharma, the merged Yamanouchi/Fujisawa
22 November 2004
Tokyo pharma stocks - week to October 25
1 November 2004
Fujisawa fiscal 1st qtr 2005 sales dip 0.5%
16 August 2004
Promising new data for Fujisawa's Protopic
19 July 2004
Tokyo pharma stocks - week to june 28
5 July 2004
Fujisawa's Protopic improves quality of life
7 June 2004
Tokyo pharma stocks - week to May 3
10 May 2004
Tokyo pharma stocks - week to March 22
29 March 2004
Fujisawa updates status of pipeline
8 March 2004
Tokyo pharma stocks - week to Mar 1
8 March 2004
Tokyo pharma stocks - week to Feb 23
1 March 2004
Fujisawa reports 9-mth sales of 315B yen
23 February 2004
Tokyo pharma stocks - week to Feb 9
16 February 2004
Roche to sell Fujisawa's Protopic
9 February 2004
Tokyo pharma stocks - week to Dec 15
22 December 2003
Tokyo pharma stocks - week to Dec 8
15 December 2003
Japan's Fujisawa sets out plans for continuous growth
8 December 2003
Letter to the Editor
24 November 2003
Fujisawa below par in fiscal first half
10 November 2003
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
